Clinical trial
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and…
NCT00396448 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00396448 |
|---|---|
| Title | Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety. |
| Official title | A 2-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of CP-945,598 In The Treatment Of Obese Subjects |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | CP-945, 598 Treatment B, 598 Treatment A, Placebo |
| Enrollment | 1,253 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Nov 7, 2006 |
| Last update posted | Nov 7, 2012 |
| Countries | Argentina, Australia, Chile, France, Germany, Mexico, South Korea, Spain, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: